Roche, a pharmaceutical company, announced that the U.S. Food and Drug Administration approved the cobas TaqScreen MPX Test, v2.0.
The test can be used in the detection and identification of HIV, Hepatitis C virus and Hepatitis B virus in human blood. This is the latest version of the cobas TaqScreen MPX Test and it provides increased sensitivity. It uses real-time, multi-dye PCR technology to detect and discriminate for HIV, HCV and HBV.
The test has received the CE Mark and has been approved in Canada, Brazil, China and India.
More articles on gastroenterology:
Hunterdon Healthcare opens reflux and motility center
Dr. Jennifer Leigh joins Gastroenterology Associates of Manatee
11 GI physicians recently in the news